Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Parkway Life Real Estate Investment ( (SG:C2PU) ) is now available.
Parkway Life REIT, through its trustee HSBC Institutional Trust Services (Singapore) Limited, has entered into a new facility agreement dated 20 February 2026 to refinance its existing bank borrowings. The move is part of its ongoing capital management strategy and affects an aggregate level of facilities of about S$887.0 million, excluding undrawn loan amounts.
Under the facility terms, the borrower must prepay outstanding amounts if Parkway Trust Management Limited resigns or is removed as manager of the REIT, unless lenders agree otherwise, or if Parkway Holdings Limited ceases to own at least 51% of the manager and no revised terms are agreed within a set negotiation period. The company stated that no such prepayment events have occurred as of the announcement date, signaling business and management continuity for now.
The most recent analyst rating on (SG:C2PU) stock is a Buy with a S$5.45 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.
More about Parkway Life Real Estate Investment
Parkway Life Real Estate Investment Trust is a Singapore-based healthcare-focused real estate investment trust managed by Parkway Trust Management Limited. It primarily invests in income-producing real estate used for healthcare and healthcare-related purposes, positioning itself as a key player in the regional healthcare infrastructure sector.
Average Trading Volume: 771,331
Technical Sentiment Signal: Strong Buy
Current Market Cap: S$2.65B
For a thorough assessment of C2PU stock, go to TipRanks’ Stock Analysis page.